Accumulation of N(ε)-(carboxymethyl)lysine and changes in glomerular extracellular matrix components in Otsuka Long-Evans Tokushima Fatty rat: A model of spontaneous NIDDM

Nephron

Volumn 79, Issue 4, 1998, Pages 458-468

  Kushiro, Masahiko ^a   Shikata, Kenichi ^a   Sugimoto, Hikaru ^a   Ikeda, Kazuyoshi ^b   Horiuchi, Seikoh ^b   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Collagen; Diabetic nephropathy; Extracellular matrix; N( ) (carboxymethyl)lysine; OLETF rat; Transforming growth factor beta

Indexed keywords

COLLAGEN TYPE 6; FIBRONECTIN; LYSINE; PROTEOHEPARAN SULFATE; TRANSFORMING GROWTH FACTOR BETA1; ADVANCED GLYCATION END PRODUCT; DRUG DERIVATIVE; EPSILON N METHYLLYSINE; EPSILON-N-METHYLLYSINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS; GLYCATION; INBRED STRAIN; MALE; MESANGIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PATHOLOGY; RAT STRAIN; TIME; ULTRASTRUCTURE;

ANIMALS; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOENZYME TECHNIQUES; KIDNEY GLOMERULUS; LYSINE; MALE; MICROSCOPY, ELECTRON; RATS; RATS, INBRED STRAINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031595742     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045093     Document Type: Article

References (12)

1. Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS: Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 1993;68:45-55.
2. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22:736-744.
3. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 1992;41:671-678.
4. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
5. Maillard LC: Actions des acides aminés sur les sucres: formation des mélanoïdines par voie méthodique. C R Hebd Séanc Acad Sci 1912;154:66-68.
6. Rahbar S: An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 1968;22:296-298.
7. Day JF, Thorpe SR, Baynes JW: Nonenzymatically glucosylated albumin: In vitro preparation and isolation from normal human serum. J Biol Chem 1979;254:595-597.
8. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-151.
9. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984;101:527-537.
10. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR: Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986;314:403-408.
11. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-1321.
12. Schnider SL, Kohn RR: Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J Clin Invest 1981;67:1630-1635.